Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Shares Outstanding (Diluted Average): 2021-2024

Historic Shares Outstanding (Diluted Average) for CorMedix (CRMD) over the last 3 years, with Dec 2024 value amounting to $58.9 million.

  • CorMedix's Shares Outstanding (Diluted Average) rose 24.81% to $71.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $71.9 million, marking a year-over-year increase of 24.81%. This contributed to the annual value of $58.9 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, CorMedix's Shares Outstanding (Diluted Average) is $58.9 million, which was up 46.18% from $40.3 million recorded in FY2022.
  • CorMedix's 5-year Shares Outstanding (Diluted Average) high stood at $58.9 million for FY2024, and its period low was $37.7 million during FY2021.
  • Moreover, its 2-year median value for Shares Outstanding (Diluted Average) was $49.6 million (2022), whereas its average is $49.6 million.
  • Data for CorMedix's Shares Outstanding (Diluted Average) shows a peak YoY grew of 6.92% (in 2022) over the last 5 years.
  • Yearly analysis of 3 years shows CorMedix's Shares Outstanding (Diluted Average) stood at $37.7 million in 2021, then grew by 6.92% to $40.3 million in 2022, then reached $58.9 million in 2024.